Corticosteroid Treatment for Iatrogenic Facial Nerve Palsy
Introduction to Treatment
- The American Academy of Otolaryngology-Head and Neck Surgery recommends treating iatrogenic facial nerve palsy with prednisolone 50 mg daily for 10 days, or prednisone 60 mg daily for 5 days followed by a 5-day taper, initiated within 72 hours of injury onset 1
Treatment Timing and Dosing
- Initiate corticosteroids within 72 hours of facial nerve injury to maximize recovery potential, as treatment beyond this window lacks evidence of benefit 1, 2
- The 72-hour window exists because early corticosteroid treatment reduces facial nerve inflammation before permanent damage occurs 2
- Prednisolone 50 mg once daily for 10 days achieves 83% recovery at 3 months versus 63.6% with placebo 1
- Maximum dose should not exceed 60 mg daily 3
- Administer as single daily dose, not divided doses, to optimize therapeutic effect 3
Critical Pitfalls to Avoid
- Avoid methylprednisolone dose packs, as they provide only 84 mg total over 6 days, which is grossly inadequate compared to 540 mg prednisone over 14 days for a 60-kg adult 3
- Do not initiate steroids beyond 72 hours, as this provides minimal benefit and exposes patients to medication risks without proven efficacy 1, 2
Essential Concurrent Management
- Implement aggressive eye protection immediately for any patient with impaired eye closure to prevent corneal damage 1, 2
- Refer to ophthalmology immediately for severe impairment or persistent lagophthalmos 1
- Mandatory reassessment or specialist referral at 3 months if incomplete recovery 1, 4
Evidence Quality and Nuances
- The recommendation for corticosteroids is based on high-quality evidence showing 94.4% recovery at 9 months with prednisolone versus 81.6% with placebo 1
- Complete paralysis patients achieve 70% full recovery within 6 months; incomplete paralysis patients achieve up to 94% recovery 1